Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7PPN

SHP2 catalytic domain in complex with CD28 (183-198) phosphopeptide (pTyr-191, p-Thr-195)

Summary for 7PPN
Entry DOI10.2210/pdb7ppn/pdb
DescriptorTyrosine-protein phosphatase non-receptor type 11,Tyrosine-protein phosphatase non-receptor type 11, T-cell-specific surface glycoprotein CD28, GLYCEROL, ... (4 entities in total)
Functional Keywordsshp2, phosphatase, cd28, phosphopeptide, signaling, signaling protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight34920.34
Authors
Sok, P.,Zeke, A.,Remenyi, A. (deposition date: 2021-09-14, release date: 2022-09-07, Last modification date: 2024-01-31)
Primary citationZeke, A.,Takacs, T.,Sok, P.,Nemeth, K.,Kirsch, K.,Egri, P.,Poti, A.L.,Bento, I.,Tusnady, G.E.,Remenyi, A.
Structural insights into the pSer/pThr dependent regulation of the SHP2 tyrosine phosphatase in insulin and CD28 signaling.
Nat Commun, 13:5439-5439, 2022
Cited by
PubMed Abstract: Serine/threonine phosphorylation of insulin receptor substrate (IRS) proteins is well known to modulate insulin signaling. However, the molecular details of this process have mostly been elusive. While exploring the role of phosphoserines, we have detected a direct link between Tyr-flanking Ser/Thr phosphorylation sites and regulation of specific phosphotyrosine phosphatases. Here we present a concise structural study on how the activity of SHP2 phosphatase is controlled by an asymmetric, dual phosphorylation of its substrates. The structure of SHP2 has been determined with three different substrate peptides, unveiling the versatile and highly dynamic nature of substrate recruitment. What is more, the relatively stable pre-catalytic state of SHP2 could potentially be useful for inhibitor design. Our findings not only show an unusual dependence of SHP2 catalytic activity on Ser/Thr phosphorylation sites in IRS1 and CD28, but also suggest a negative regulatory mechanism that may also apply to other tyrosine kinase pathways as well.
PubMed: 36114179
DOI: 10.1038/s41467-022-32918-5
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon